Mary Pillai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary Pillai has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- A Caroline Gazet
Associate Specialist in Sexual & Reproductive Health, Gloucestershire Care Services NHS Trust, Sexual Health Service, Gloucestershire Royal Hospital, Gloucester, UK;
1 shared publication E Hill
Bristol University Medical School, Bristol, UK
1 shared publicationJulia Shefras
Consultant in Sexual and Reproductive Health, Alec Turnbull Centre, Oxford, UK
1 shared publicationK O’bRien
Department of Obstetrics & Gynaecology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham General Hospital, Cheltenham, UK
1 shared publication- Megan Griffiths
ST5 in Community Sexual & Reproductive Health, Norfolk and Norwich University Hospital Trust, Contraception and Sexual Health Clinic, Norwich, UK;
1 shared publication Sheila Paul
1 shared publication
Latest Publications
- Open Access
- 22 September 2015
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 41 (4) , 316.2-316
Comment on ‘Ultrasound-guided retrieval of lost intrauterine devices using very fine grasping forceps: a case series’
- 22 September 2015
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 41 (4) , 316.2-316
Open AccessComment on ‘Ultrasound-guided retrieval of lost intrauterine devices using very fine grasping forceps: a case series’
- Open Access
- 17 June 2014
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 40 (3) , 234.2-234
Comment on ‘Continuing need for and provision of a service for non-standard implant removal’: authors’ response
- 17 June 2014
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 40 (3) , 234.2-234
Open AccessComment on ‘Continuing need for and provision of a service for non-standard implant removal’: authors’ response
- Open Access
- 19 March 2014
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 40 (2) , 151-152
Comment on ‘Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives’
- 19 March 2014
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 40 (2) , 151-152
Open AccessComment on ‘Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives’
- Open Access
- 15 September 2011
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 38 (2) , 110-116
Experience with Instillagel® for hysterosonography and analgesia in a complex contraception clinic: a QIPP initiative
Background: A significant number of women are referred with bleeding problems related to the use of hormonal contraception, for advice on management of heavy periods or following difficulty with intrauterine device insertion. The authors describe their experience with Instillagel®as the contrast medium for hysterosonography in a one-stop clinic for complex contraception referrals. They also comment on its analgesic properties for cervical and uterine instrumentation.Methods: The authors reviewed 275 referrals seen over a 6-month period in consultant-delivered clinics provided by a contraception service that serves a single county (population 500 000). They describe the simple technique they use for hysterosonography with Instillagel.Results: The authors found Instillagel useful as a contrast medium for sonographic assessment of the endometrial cavity. Additionally, presence of gel in the endometrial cavity, with a time interval between insertion of gel and uterine instrumentation, appears to result in analgesia and relaxation of the uterus. There was a very low incidence of difficulties in a group of patients who had previously experienced significant problems with uterine instrumentation.Conclusions: Hysterosonography is an efficacious, simple and inexpensive technique for assessment of the endometrial cavity. It has many potential applications in contraceptive care. An additional benefit appeared to be that once gel was instilled in the cavity for 10–15 minutes it facilitated instrumentation of the uterus.
- 15 September 2011
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 38 (2) , 110-116
Open AccessExperience with Instillagel® for hysterosonography and analgesia in a complex contraception clinic: a QIPP initiative
Background: A significant number of women are referred with bleeding problems related to the use of hormonal contraception, for advice on management of heavy periods or following difficulty with intrauterine device insertion. The authors describe their experience with Instillagel®as the contrast medium for hysterosonography in a one-stop clinic for complex contraception referrals. They also comment on its analgesic properties for cervical and uterine instrumentation.Methods: The authors reviewed 275 referrals seen over a 6-month period in consultant-delivered clinics provided by a contraception service that serves a single county (population 500 000). They describe the simple technique they use for hysterosonography with Instillagel.Results: The authors found Instillagel useful as a contrast medium for sonographic assessment of the endometrial cavity. Additionally, presence of gel in the endometrial cavity, with a time interval between insertion of gel and uterine instrumentation, appears to result in analgesia and relaxation of the uterus. There was a very low incidence of difficulties in a group of patients who had previously experienced significant problems with uterine instrumentation.Conclusions: Hysterosonography is an efficacious, simple and inexpensive technique for assessment of the endometrial cavity. It has many potential applications in contraceptive care. An additional benefit appeared to be that once gel was instilled in the cavity for 10–15 minutes it facilitated instrumentation of the uterus.
- 9 December 2009
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (2) , 216-221
The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities
Please cite this paper as: Pillai M, O’Brien K, Hill E. The levonorgestrel IUS (Mirena) for the treatment of menstrual problems in adolescents with medical disorders or physical or learning disabilities. BJOG 2010;117:216–221.Menstrual problems are common in adolescence. Management can be very problematic in girls with disability or medical disorders, as their condition and other medications may mean they are less likely to achieve satisfactory control with standard medical treatments. Those with disability tend to tolerate menses poorly. We report experience with the levonorgestrel intrauterine system (LNG IUS) for treatment of menstrual problems in adolescents with a range of medical problems or with severe learning disability. It provided of significant therapeutic benefit for 12 of 14 participants, with the majority opting to continue for the 5‐year duration of the device. The rates of expulsion, bleeding and amenorrhoea appear similar to those reported in older women, where contraception is the primary indication.
- 9 December 2009
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (2) , 216-221
The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities
Please cite this paper as: Pillai M, O’Brien K, Hill E. The levonorgestrel IUS (Mirena) for the treatment of menstrual problems in adolescents with medical disorders or physical or learning disabilities. BJOG 2010;117:216–221.Menstrual problems are common in adolescence. Management can be very problematic in girls with disability or medical disorders, as their condition and other medications may mean they are less likely to achieve satisfactory control with standard medical treatments. Those with disability tend to tolerate menses poorly. We report experience with the levonorgestrel intrauterine system (LNG IUS) for treatment of menstrual problems in adolescents with a range of medical problems or with severe learning disability. It provided of significant therapeutic benefit for 12 of 14 participants, with the majority opting to continue for the 5‐year duration of the device. The rates of expulsion, bleeding and amenorrhoea appear similar to those reported in older women, where contraception is the primary indication.
- 1 August 2008
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 21 (4) , 177-185
Genital Findings in Prepubertal Girls: What Can Be Concluded from an Examination?
- 1 August 2008
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 21 (4) , 177-185
Genital Findings in Prepubertal Girls: What Can Be Concluded from an Examination?
- 1 November 2007
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 14 (8) , 503-514
An evaluation of ‘confirmatory’ medical opinion given to English courts in 14 cases of alleged child sexual abuse
- 1 November 2007
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 14 (8) , 503-514
An evaluation of ‘confirmatory’ medical opinion given to English courts in 14 cases of alleged child sexual abuse
- 1 May 2006
- Published by Elsevier in Journal of Clinical Forensic Medicine
- Vol. 13 (4) , 164-171
Facilities for complainants of sexual assault throughout the United Kingdom
- 1 May 2006
- Published by Elsevier in Journal of Clinical Forensic Medicine
- Vol. 13 (4) , 164-171
Facilities for complainants of sexual assault throughout the United Kingdom
- 1 April 2005
- Published by Elsevier in Journal of Clinical Forensic Medicine
- Vol. 12 (2) , 57-63
Forensic examination of suspected child victims of sexual abuse in the UK: a personal view
- 1 April 2005
- Published by Elsevier in Journal of Clinical Forensic Medicine
- Vol. 12 (2) , 57-63
Forensic examination of suspected child victims of sexual abuse in the UK: a personal view